Vivos (RDGL) Cash & Equivalents (2010 - 2025)

Vivos has disclosed Cash & Equivalents across 16 years of filings, most recently posting $1.6 million for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 29.56% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (down 29.56% YoY), while the FY2025 annual figure was $1.6 million, down 29.56% from the prior year.
• Cash & Equivalents came in at $1.6 million for Q4 2025 at Vivos, down from $2.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $3.3 million in Q1 2025 to a low of $1.1 million in Q2 2022.
• Average Cash & Equivalents over 5 years is $1.8 million, with a median of $1.7 million recorded in 2022.
• Year-over-year, Cash & Equivalents soared 13202.47% in 2021 and sank 51.46% in 2022.
• Over 5 years, Cash & Equivalents stood at $1.6 million in 2021, then grew by 6.22% to $1.7 million in 2022, then decreased by 6.67% to $1.6 million in 2023, then surged by 38.95% to $2.2 million in 2024, then decreased by 29.56% to $1.6 million in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $1.6 million in Q4 2025, $2.2 million in Q3 2025, and $2.7 million in Q2 2025.